Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 264-120-7 | CAS number: 63393-96-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
3 OECD TG GLP studies:
- OECD TG 471 (Bacterial Reverse Mutation Assay): negative
- OECD TG 476 (In Vitro Mammalian Cell Gene Mutation Test): negative
- OECD TG 487 (In Vitro Mammalian Cell Micronucleus Test): negative
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
OECD TG 471 - Bacterial Reverse Mutation Assay
A bacterial reverse mutation assay was performed equivalent to OECD guideline 471 under GLP conditions. The Salmonella typhimurium strains TA100, TA1535, TA1537, TA98 and Escherichia coli strain E. coli WP2 uvrA were incubated with the test substance at concentrations of 0.1 - 5500 µg/plate (Standard plate test, SPT) and 0.03 - 100 µg/plate (Preincubation test, PIT) without and with metabolic activation (liver S9 mix from induced rats). The PIT was carried out using a pre-incubation of 20 minutes followed by a plate incorporation assay with an expression time of 48 hours. For the SPT no pre-incubtaion step was performed. Appropriate positive controls and a vehicle control were also tested.
No precipitation of the test substance was found with and without S9 mix.
A strong bacteriotoxic effect was observed depending on the strain and test conditions from about 0.3 μg/plate onward.
A relevant increase in the number of his+ or trp+ revertants (factor ≥ 2: TA 100, TA 98 and E.coli WP2 uvrA or factor ≥ 3: TA 1535 and TA 1537) was not observed in the standard plate test or in the preincubation test without S9 mix or after the addition of a metabolizing system.
Under the experimental conditions of this study, the test substance was not mutagenic in the Salmonella typhimurium/Escherichia coli reverse mutation assay in the absence and the presence of metabolic activation.
OECD TG 476 - In Vitro Mammalian Cell Gene Mutation Test
The vitro mammalian cell gene mutation test was performed in two independent experiments, using two parallell cultures of V79 cells each, according to OECD guideline 476 under GLP conditions. The first main experiment was performed with a treatment period of 4 hours with and without microsomal activation. The second main experiment was performed with a 24 hours treatment period without microsomal activation and a 4 hours treatment period with microsomal activation. The maximum test item concentration of the pre-experiment (2208.0 μg/mL) was chosen with respect to the current OECD guideline 476 regarding the content of the test item.
No substantial and reproducible dose dependent increase of the mutation frequency was observed in the main experiments. Therefore, the test substance is considered as non-mutagenic in this HPRT assay.
Appropriate reference mutagens, used as positive controls, induced a distinct increase in mutant colonies and thus, showed the sensitivity of the test system and the activity of the metabolic activation system.
OECD TG 487 - In Vitro Mammalian Cell Micronucleus Test
To assess its potential to induce micronuclei in human lymphocytes in vitro in the absence and presence of metabolic activation by S9 mix an in vitro mammalian cell micronucleus test was performed according to OECD guideline 487 under GLP conditions.
Two independent experiments were performed. In Experiment I, the exposure period was 4 hours with and without S9 mix. In Experiment II, the exposure period was 20 hours without S9 mix. The cells were prepared 40 hours after start of treatment with the test item.
In each experimental group two parallel cultures were analyzed. 1000 binucleate cells per culture were evaluated for cytogenetic damage on coded slides. Dose selection of the cytogenetic experiment was performed considering the toxicity data and the occurrence of test item phase separation in accordance with OECD guideline 487.
In Experiment I in the absence and presence of S9 mix, clear cytotoxicity was observed to the highest evaluated concentration. In Experiment II in the absence of S9 mix, concentrations showing clear cytotoxicity were not evaluable for cytogenetic damage.
In the absence and presence of S9 mix, no relevant increases in the numbers of micronucleated cells were observed after treatment with the test item. Therefore, the test substance is considered to be non-mutagenic in this in vitro micronucleus test, when tested up to cytotoxic or to the highest evaluable concentration.
Appropriate mutagens were used as positive controls. They induced statistically significant increases in cells with micronuclei.
In conclusion, it can be stated that the test item was not mutagenic in the bacterial reverse mutation assay and in the HPRT assay and did not induce micronuclei as determined by the in vitro micronucleus test in human lymphocytes.
Justification for classification or non-classification
The available experimental test data are reliable and suitable for classification purposes under Regulation 1272/2008. As a result, the substance is not considered to be classified for genotoxicity under Regulation (EC) No. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
